FDA Adverse Event Malfunction Summary report: N

FT4, FREE THYROXINE

MDR report key: 4476386 · Received February 2, 2015

Report

Report Number
1823260-2015-00785
Event Type
Malfunction
Date Received
February 2, 2015
Date of Event
January 13, 2015
Report Date
February 18, 2015
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CEC
PMA / PMN Number
K961489
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6). REFER TO THE MEDWATCH WITH PATIENT IDENTIFIER (B)(6) FOR THE THYROTROPIN (TSH) ASSAY.

Additional Manufacturer Narrative · 1

FURTHER INVESTIGATION CONFIRMED THE CUSTOMER'S RESULTS ON A SIEMENS CENTAUR ANALYZER. A GENERAL REAGENT ISSUE COULD BE EXCLUDED.

Description of Event or Problem · 1

THE CUSTOMER RECEIVED QUESTIONABLE THYROTROPIN (TSH) AND FREE THYROXINE (FT4) RESULTS FOR ONE PATIENT FROM THE COBAS E601 ANALYZER SERIAL NUMBER 2440-15. THE INITIAL TSH RESULT WAS APPROXIMATELY 1.3 UUI/ML AND FT4 RESULT WAS APPROXIMATELY 30 PMOL/L. ON (B)(6) 2015, TWO SAMPLES FROM THE PATIENT DRAWN ON (B)(6) 2015 WERE TESTED. IT WAS UNKNOWN IF EITHER OF THESE SAMPLES WAS THE SAMPLE THAT WAS USED TO GENERATE THE INITIAL RESULTS. SAMPLE 1 COLLECTED IN THE MORNING, TSH RESULT WAS 2.62 UUI/ML AND FT4 WAS 32.68 PMOL/L. SAMPLE 2 COLLECTED IN THE AFTERNOON, TSH RESULT WAS 1.39 UUI/ML AND FT4 WAS 66.71 PMOL/L. THE RESULTS WERE REPORTED OUTSIDE THE LABORATORY. NO ADVERSE EVENT WAS REPORTED. SAMPLE FROM THE PATIENT WAS SUBMITTED FOR INVESTIGATION AND THE CUSTOMER'S HIGH FT4 RESULTS WERE REPRODUCED. THE TSH RESULTS WERE FOUND TO BE WITHIN THE REFERENCE RANGE. NO INTERFERING FACTOR TO STREPTAVIDIN WAS FOUND IN THE SAMPLES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
75645 FT4, FREE THYROXINE RADIOIMMUNOASSAY, FREE THYROXINE CEC ROCHE DIAGNOSTICS NA 179279

Patients

Seq Age Sex Outcome Treatment
1 025 MO